1	Una	Una		C0205447_1	calificador_1	0-3	404_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
2	paciente	paciente	NCCS000	C0030705	persona	4-12	404_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
3	de	de	SPS00	C0332285	atributo	13-15	404_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
4	72	72		-	-	16-18	404_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
5	años	año	NCMP000	C0439234	calificador	19-23	404_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
6	fue	ser	VSIS3S0	-	-	24-27	404_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
7	vista	ver	VMP00SF	-	-	28-33	404_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
8	en	en	SPS00	C1720294#C0332285	calificador#atributo	34-36	404_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
9	Urgencias	urgencia	NCFP000	C0439609	calificador	37-46	404_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
10	un	un		C0205447_1	calificador_1	47-49	404_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
11	mes	mes	NCMS000	C0439231	calificador	50-53	404_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
12	antes	antes	RG	C0332152	atributo	54-59	404_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
13	por	por	SPS00	C0678226	atributo	60-63	404_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
14	caída	caída	NCFS000	C0085639	hallazgo	64-69	404_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	17	4968	Causada_por
15	casual	casual	AQ0CS0	C0521129	calificador	70-76	404_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
16	y	y	CC	C1706368	calificador	77-78	404_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
17	traumatismo	traumatismo	NCMS000	C3263723	trastorno	79-90	404_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
18	de	de	SPS00	C0332285	atributo	91-93	404_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
19	rodilla	rodilla	NCFS000	C1963703#C1456798	estructura_corporal	94-101	404_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-	17	4968	LOC
20	.	.	Fp	-	-	101-102	404_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-

1	Consulta	consulta	NCFS000	C3543841#C0009818	metadato_fundacional#procedimiento	103-111	404_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
2	de	de	SPS00	C0332285	atributo	112-114	404_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
3	nuevo	nuevo	NC00SC0	C0205314	calificador	115-120	404_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
4	por	por	SPS00	C0678226	atributo	121-124	404_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
5	dolor	dolor	NCMS000	C0024031_1	trastorno_1	125-130	404_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-	-	-	-
6	lumbar	lumbar	NC00SC0	C0024031_2	trastorno_2	131-137	404_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-	5	4969	LOC
7	bilateral	bilateral	AQ0CS0	C0238767	calificador	138-147	404_QUEST_clinical_caseMIR	SENT2	I-Estructura_Corporal	-	6	15	MultiE
8	y	y	CC	C1706368	calificador	148-149	404_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
9	orinas	orina	NCFP000	C0042036	sustancia	150-156	404_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-	-	-	-
10	oscuras	oscuro	AQ0FP0	C0332582	calificador	157-164	404_QUEST_clinical_caseMIR	SENT2	I-Grp_Enfermedad	-	9	43	MultiE
11	desde	desde	SPS00	-	-	165-170	404_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
12	hace	hacer	VMIP3S0	-	-	171-175	404_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
13	una	una		C0205447_1	calificador_1	176-179	404_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
14	semana	semana	NCFS000	C0439230	calificador	180-186	404_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
15	.	.	Fp	-	-	186-187	404_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-

1	Como	como	CS	C0332257	calificador	188-192	404_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
2	antecedentes	antecedente	NCMP000	-	-	193-205	404_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
3	destacan	destacar	VMIP3P0	-	-	206-214	404_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
4	HTA	hta	NC00YL0	-	-	215-218	404_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-	-	-	-
5	,	,	Fc	-	-	218-219	404_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
6	diabetes	diabetes	NCFN000	C0011860_1	trastorno_1	220-228	404_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-	-	-	-
7	mellitus	mellitus	AQ0CN0	C0011860_2	trastorno_2	229-237	404_QUEST_clinical_caseMIR	SENT3	I-Grp_Enfermedad	-	6	15	MultiE
8	no	no	RN	C0011860_3	trastorno_3	238-240	404_QUEST_clinical_caseMIR	SENT3	B-Calificador	-	6	4970	Modif
9	insulinodependiente	insulinodependiente		C0011860_4	trastorno_4	241-260	404_QUEST_clinical_caseMIR	SENT3	I-Calificador	-	8	41	MultiE
10	,	,	Fc	-	-	260-261	404_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
11	dislipemia	dislipemia	NCFS000	-	-	262-272	404_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-	-	-	-
12	,	,	Fc	-	-	272-273	404_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
13	obesidad	obesidad	NCFS000	C0028754#C0451819#C1563743	trastorno	274-282	404_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-	-	-	-
14	y	y	CC	C1706368	calificador	283-284	404_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
15	gonartrosis	gonartrosis	NC00KE0	-	-	285-296	404_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-	-	-	-
16	.	.	Fp	-	-	296-297	404_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-

1	Sigue	seguir	VMIP3S0	-	-	298-303	404_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
2	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	304-315	404_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
3	con	con	SPS00	C0332287	atributo	316-319	404_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
4	enalapril	enalapril	NC00SC0	C0014025	sustancia	320-329	404_QUEST_clinical_caseMIR	SENT4	B-Grp_Medicamento	-	-	-	-
5	/	/	Fh	-	-	329-330	404_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
6	hidroclorotiazida	hidroclorotiazida	NCMS000	C0020261	producto#sustancia	330-347	404_QUEST_clinical_caseMIR	SENT4	B-Grp_Medicamento	-	-	-	-
7	20/12,5	20/12,5	Z	-	-	348-355	404_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
8	mg	mg	NCMN000	-	-	356-358	404_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
9	/	/	Fh	-	-	358-359	404_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
10	día	día	NCMS000	C0439228#C0332169	calificador	359-362	404_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
11	,	,	Fc	-	-	362-363	404_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
12	naproxeno	naproxeno	NC00SC0	C0027396	sustancia	364-373	404_QUEST_clinical_caseMIR	SENT4	B-Grp_Medicamento	-	-	-	-
13	a	a	SPS00	-	-	374-375	404_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
14	demanda	demanda	NCFS000	C0441516	calificador	376-383	404_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
15	,	,	Fc	-	-	383-384	404_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
16	atorvastatina	atorvastatina	NC00SC0	C0286651	producto#sustancia	385-398	404_QUEST_clinical_caseMIR	SENT4	B-Grp_Medicamento	-	-	-	-
17	20	20	Z	-	-	399-401	404_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
18	mg	mg	NCMN000	-	-	402-404	404_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
19	/	/	Fh	-	-	404-405	404_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
20	día	día	NCMS000	C0439228#C0332169	calificador	405-408	404_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
21	y	y	CC	C1706368	calificador	409-410	404_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
22	metformina	metformina	NC00SC0	C0025598	producto#sustancia	411-421	404_QUEST_clinical_caseMIR	SENT4	B-Grp_Medicamento	-	-	-	-
23	850	850	Z	-	-	422-425	404_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
24	mg	mg	NCMN000	-	-	426-428	404_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
25	/	/	Fh	-	-	428-429	404_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
26	día	día	NCMS000	C0439228#C0332169	calificador	429-432	404_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
27	.	.	Fp	-	-	432-433	404_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	434-436	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
2	la	el	DA0FS0	-	-	437-439	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
3	analítica	analítica	NCFS000	-	-	440-449	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
4	de	de	SPS00	C0332285	atributo	450-452	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
5	urgencia	urgencia	NCFS000	C0439609	calificador	453-461	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
6	destaca	destacar	VMIP3S0	-	-	462-469	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
7	:	:	Fd	-	-	469-470	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
8	anemia	anemia	NCFS000	C0085576_1	trastorno_1	471-477	404_QUEST_clinical_caseMIR	SENT5	B-Grp_Enfermedad	-	-	-	-
9	microcítica	microcítico	AQ0FS0	C0085576_2	trastorno_2	478-489	404_QUEST_clinical_caseMIR	SENT5	B-Calificador	-	8	4972	Modif
10	moderada	moderar	VMP00SF	-	-	490-498	404_QUEST_clinical_caseMIR	SENT5	B-Calificador	-	8	4972	Modif
11	,	,	Fc	-	-	498-499	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
12	ácido	ácido	NCMS000	C0041980_1	sustancia_1	500-505	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
13	úrico	úrico	AQ0MS0	C0041980_2	sustancia_2	506-511	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
14	9,5	9.5	Z	-	-	512-515	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
15	mg	mg	NCMN000	-	-	516-518	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
16	/	/	Fh	-	-	518-519	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
17	dL	decilitro	NCMN000	C0439241	calificador	519-521	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
18	;	;	Fx	-	-	521-522	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
19	CPK	creatine_phosfhokinase_(creatinfosfocinasa)	NC00YL0	-	-	523-526	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
20	45	45		-	-	527-529	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
21	U	o	CC	-	-	530-531	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
22	/	/	Fh	-	-	531-532	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
23	L	l	NCFS000	-	-	532-533	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
24	;	;	Fx	-	-	533-534	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
25	creatinina	creatinina	NC00SC0	C0010294	sustancia	535-545	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
26	1,9	1.9	Z	-	-	546-549	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
27	mg	mg	NCMN000	-	-	550-552	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
28	/	/	Fh	-	-	552-553	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
29	dL	decilitro	NCMN000	C0439241	calificador	553-555	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
30	;	;	Fx	-	-	555-556	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
31	urea	urea	NCFS000	C0041942	sustancia	557-561	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
32	75	75	Z	-	-	562-564	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
33	mg	mg	NCMN000	-	-	565-567	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
34	/	/	Fh	-	-	567-568	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
35	dL	decilitro	NCMN000	C0439241	calificador	568-570	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
36	;	;	Fx	-	-	570-571	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
37	Na	noradrenalina	NC00YL0	C0028351	producto#sustancia	572-574	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
38	138	138		-	-	575-578	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
39	mEq	miliequivalente_(10-3_mol_dividido_por_la_valencia)	NC00YL0	-	-	579-582	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
40	/	/	Fh	-	-	582-583	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
41	L	l	NCFS000	-	-	583-584	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
42	;	;	Fx	-	-	584-585	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
43	K	k	NCFS000	-	-	586-587	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
44	5,6	5,6		-	-	588-591	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
45	mEq	miliequivalente_(10-3_mol_dividido_por_la_valencia)	NC00YL0	-	-	592-595	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
46	/	/	Fh	-	-	595-596	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
47	L.	l.	NCFS000	-	-	596-598	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
48	En	en	SPS00	C1720294#C0332285	calificador#atributo	599-601	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
49	la	el	DA0FS0	-	-	602-604	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
50	orina	orina	NCFS000	C0042036	sustancia	605-610	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
51	:	:	Fd	-	-	610-611	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
52	microhematuria	microhematuria	NC00SC0	C0239937	trastorno	612-626	404_QUEST_clinical_caseMIR	SENT5	B-Grp_Enfermedad	-	-	-	-
53	+	+	Fz	-	-	627-628	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
54	+	+	Fz	-	-	628-629	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
55	,	,	Fc	-	-	629-630	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
56	proteinuria	proteinuria	NCFS000	C0033687_1	hallazgo_1	631-642	404_QUEST_clinical_caseMIR	SENT5	B-Grp_Enfermedad	-	-	-	-
57	-	-	Fg	-	-	643-644	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
58	y	y	CC	C1706368	calificador	645-646	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
59	muy	muy	RG	C0442824	calificador	647-650	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
60	abundantes	abundante	AQ0CP0	-	-	651-661	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
61	células	célula	NCFP000	C1269647#C0007634	célula#estructura_corporal	662-669	404_QUEST_clinical_caseMIR	SENT5	B-Grp_Enfermedad	-	-	-	-
62	descamativas	descamativo	AQ0FP0	-	-	670-682	404_QUEST_clinical_caseMIR	SENT5	I-Grp_Enfermedad	-	61	4957	MultiE
63	.	.	Fp	-	-	682-683	404_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-

1	No	no	RN	C1298908	calificador	684-686	404_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
2	se	se	P00CN000	-	-	687-689	404_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
3	observan	observar	VMIP3P0	-	-	690-698	404_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
4	bacterias	bacteria	NCFP000	C0004611	organismo	699-708	404_QUEST_clinical_caseMIR	SENT6	B-Grp_Enfermedad	Negacion	-	-	-
5	.	.	Fp	-	-	708-709	404_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	710-712	404_QUEST_clinical_caseMIR	SENT7	-	-	-	-	-
2	la	el	DA0FS0	-	-	713-715	404_QUEST_clinical_caseMIR	SENT7	-	-	-	-	-
3	visita	visita	NCFS000	-	-	716-722	404_QUEST_clinical_caseMIR	SENT7	-	-	-	-	-
4	anterior	anterior	NC00SC0	C0205094#C1704448	calificador	723-731	404_QUEST_clinical_caseMIR	SENT7	-	-	-	-	-
5	a	a	SPS00	-	-	732-733	404_QUEST_clinical_caseMIR	SENT7	-	-	-	-	-
6	Urgencias	urgencia	NCFP000	C0439609	calificador	734-743	404_QUEST_clinical_caseMIR	SENT7	-	-	-	-	-
7	hace	hacer	VMIP3S0	-	-	744-748	404_QUEST_clinical_caseMIR	SENT7	-	-	-	-	-
8	1	1		-	-	749-750	404_QUEST_clinical_caseMIR	SENT7	-	-	-	-	-
9	mes	mes	NCMS000	C0439231	calificador	751-754	404_QUEST_clinical_caseMIR	SENT7	-	-	-	-	-
10	,	,	Fc	-	-	754-755	404_QUEST_clinical_caseMIR	SENT7	-	-	-	-	-
11	todos	todo	DI0MP0	C0205197#C0439810#C0444868#C0444667	calificador	756-761	404_QUEST_clinical_caseMIR	SENT7	-	-	-	-	-
12	los	el	DA0MP0	-	-	762-765	404_QUEST_clinical_caseMIR	SENT7	-	-	-	-	-
13	parámetros	parámetro	NCMP000	C0549193	atributo	766-776	404_QUEST_clinical_caseMIR	SENT7	-	-	-	-	-
14	eran	ser	VSII3P0	-	-	777-781	404_QUEST_clinical_caseMIR	SENT7	-	-	-	-	-
15	normales	normal	AQ0CP0	C0205307	calificador	782-790	404_QUEST_clinical_caseMIR	SENT7	-	-	-	-	-
16	.	.	Fp	-	-	790-791	404_QUEST_clinical_caseMIR	SENT7	-	-	-	-	-

1	Una	Una		C0205447_1	calificador_1	792-795	404_QUEST_clinical_caseMIR	SENT8	-	-	-	-	-
2	ecografía	ecografía	NCFS000	C0041618	calificador#procedimiento	796-805	404_QUEST_clinical_caseMIR	SENT8	-	-	-	-	-
3	urgente	urgente	AQ0CS0	C0439609	calificador	806-813	404_QUEST_clinical_caseMIR	SENT8	-	-	-	-	-
4	es	ser	VSIP3S0	-	-	814-816	404_QUEST_clinical_caseMIR	SENT8	-	-	-	-	-
5	informada	informar	VMP00SF	C0700287	procedimiento	817-826	404_QUEST_clinical_caseMIR	SENT8	-	-	-	-	-
6	como	como	CS	C0332257	calificador	827-831	404_QUEST_clinical_caseMIR	SENT8	-	-	-	-	-
7	posible	posible	AQ0CS0	C0332149#C2362652	calificador	832-839	404_QUEST_clinical_caseMIR	SENT8	-	-	-	-	-
8	necrosis	necrosis	NCFN000	C0022667_1	trastorno_1	840-848	404_QUEST_clinical_caseMIR	SENT8	B-Grp_Enfermedad	Especulacion	-	-	-
9	papilar	papilar	NC00SC0	C0022667_2	trastorno_2	849-856	404_QUEST_clinical_caseMIR	SENT8	B-Estructura_Corporal	-	8	4975	Modif
10	bilateral	bilateral	AQ0CS0	C0238767	calificador	857-866	404_QUEST_clinical_caseMIR	SENT8	B-Calificador	-	8	4975	Modif
11	.	.	Fp	-	-	866-867	404_QUEST_clinical_caseMIR	SENT8	-	-	-	-	-

1	¿	¿	Fia	-	-	868-869	404_QUEST_clinical_caseMIR	SENT9	-	-	-	-	-
2	A	a	SPS00	-	-	869-870	404_QUEST_clinical_caseMIR	SENT9	-	-	-	-	-
3	qué	qué	PT0CN000	-	-	871-874	404_QUEST_clinical_caseMIR	SENT9	-	-	-	-	-
4	puede	poder	VMIP3S0	-	-	875-880	404_QUEST_clinical_caseMIR	SENT9	-	-	-	-	-
5	deber	deber	VMN0000	-	-	881-886	404_QUEST_clinical_caseMIR	SENT9	-	-	-	-	-
6	se	se	PP3CN000	-	-	886-888	404_QUEST_clinical_caseMIR	SENT9	-	-	-	-	-
7	el	el	DA0MS0	-	-	889-891	404_QUEST_clinical_caseMIR	SENT9	-	-	-	-	-
8	cuadro	cuadro	NCMS000	-	-	892-898	404_QUEST_clinical_caseMIR	SENT9	-	-	-	-	-
9	actual	actual	AQ0CS0	C0521116	calificador	899-905	404_QUEST_clinical_caseMIR	SENT9	-	-	-	-	-
10	?	?	Fit	-	-	905-906	404_QUEST_clinical_caseMIR	SENT9	-	-	-	-	-

